These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22772448)

  • 1. Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation.
    Basler M; Lauer C; Moebius J; Weber R; Przybylski M; Kisselev AF; Tsu C; Groettrup M
    J Immunol; 2012 Aug; 189(4):1868-77. PubMed ID: 22772448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiviral immune response in mice devoid of immunoproteasome activity.
    Basler M; Beck U; Kirk CJ; Groettrup M
    J Immunol; 2011 Dec; 187(11):5548-57. PubMed ID: 22013127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced immunoproteasome formation and accumulation of immunoproteasomal precursors in the brains of lymphocytic choriomeningitis virus-infected mice.
    Kremer M; Henn A; Kolb C; Basler M; Moebius J; Guillaume B; Leist M; Van den Eynde BJ; Groettrup M
    J Immunol; 2010 Nov; 185(9):5549-60. PubMed ID: 20881186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoproteasome in antigen processing and other immunological functions.
    Basler M; Kirk CJ; Groettrup M
    Curr Opin Immunol; 2013 Feb; 25(1):74-80. PubMed ID: 23219269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies.
    Bandoh N; Ogino T; Cho HS; Hur SY; Shen J; Wang X; Kato S; Miyokawa N; Harabuchi Y; Ferrone S
    Tissue Antigens; 2005 Sep; 66(3):185-94. PubMed ID: 16101829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation.
    Ito Y; Kondo E; Demachi-Okamura A; Akatsuka Y; Tsujimura K; Tanimoto M; Morishima Y; Takahashi T; Kuzushima K
    J Virol; 2006 Jan; 80(2):883-90. PubMed ID: 16378990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of experimental colitis by a selective inhibitor of the immunoproteasome.
    Basler M; Dajee M; Moll C; Groettrup M; Kirk CJ
    J Immunol; 2010 Jul; 185(1):634-41. PubMed ID: 20525886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
    Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
    J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation.
    Yewdell J; Lapham C; Bacik I; Spies T; Bennink J
    J Immunol; 1994 Feb; 152(3):1163-70. PubMed ID: 8301122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical analysis of proteasomes from mouse microglia: induction of immunoproteasomes by interferon-gamma and lipopolysaccharide.
    Stohwasser R; Giesebrecht J; Kraft R; Müller EC; Häusler KG; Kettenmann H; Hanisch UK; Kloetzel PM
    Glia; 2000 Feb; 29(4):355-65. PubMed ID: 10652445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
    Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
    J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i).
    Scheffler S; Kuckelkorn U; Egerer K; Dörner T; Reiter K; Soza A; Burmester GR; Feist E
    Rheumatology (Oxford); 2008 May; 47(5):622-6. PubMed ID: 18375405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal IFN-gamma-dependent immunoproteasome modulation by Trypanosoma cruzi-infected macrophages.
    Bergeron M; Blanchette J; Rouleau P; Olivier M
    Parasite Immunol; 2008 May; 30(5):280-92. PubMed ID: 18312504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A third interferon-gamma-induced subunit exchange in the 20S proteasome.
    Groettrup M; Kraft R; Kostka S; Standera S; Stohwasser R; Kloetzel PM
    Eur J Immunol; 1996 Apr; 26(4):863-9. PubMed ID: 8625980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 20S immunoproteasome and constitutive proteasome bind with the same affinity to PA28αβ and equally degrade FAT10.
    Schmidtke G; Schregle R; Alvarez G; Huber EM; Groettrup M
    Mol Immunol; 2019 Sep; 113():22-30. PubMed ID: 29208314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.
    Sijts AJ; Ruppert T; Rehermann B; Schmidt M; Koszinowski U; Kloetzel PM
    J Exp Med; 2000 Feb; 191(3):503-14. PubMed ID: 10662796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence information within proteasomal prosequences mediates efficient integration of beta-subunits into the 20 S proteasome complex.
    Schmidt M; Zantopf D; Kraft R; Kostka S; Preissner R; Kloetzel PM
    J Mol Biol; 1999 Apr; 288(1):117-28. PubMed ID: 10329130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of low molecular mass polypeptide complementary DNA clones from primitive vertebrates. Implications for the origin of MHC class I-restricted antigen presentation.
    Kandil E; Namikawa C; Nonaka M; Greenberg AS; Flajnik MF; Ishibashi T; Kasahara M
    J Immunol; 1996 Jun; 156(11):4245-53. PubMed ID: 8666794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoproteasome-specific inhibitors and their application.
    Basler M; Groettrup M
    Methods Mol Biol; 2012; 832():391-401. PubMed ID: 22350900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.